Fluidigm Corp (FLDM) 43.04 $FLDM Thermo Fisher Q1

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fluidigm Corp (FLDM) 43.04 $FLDM

Thermo Fisher Q1 Earnings Top, Revenues Lag Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 22, 11:10AM CDT
Thermo Fisher Scientific, Inc. (TMO) reported its first-quarter 2015 financial results.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), TMO: 130.69 (-3.75), LMNX: 16.34 (-0.01)

Inogen Gains despite Further Delay in Form 10-K Filing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 10:50AM CDT
Shares of Inogen Inc. (INGN) climbed nearly 2.4% following the announcement that it needs additional time to file its Annual Report on Form 10-K for the year ended Dec 31, 2014.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), LMNX: 16.34 (-0.01)

Thoratec Hits 52-Week High on Favorable Developments - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 16, 10:20AM CDT
Shares of Thoratec Corp (THOR) scaled a new 52-week high of $43.24 in mid-day trading on Apr 15.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), THOR: 43.00 (-0.76)

Masimo to Launch Patient SafetyNet System with Iris, MyView - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 14, 12:10PM CDT
Masimo Corp (MASI) announced the launch of Patient SafetyNet Series 5000 at the HIMSS Annual Conference and Exhibition in Chicago.
ABMD: 69.31 (-0.40), MASI: 34.96 (+0.43), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04)

qPCR and dPCR Instrumentation Market: Educational/Research, Testing Laboratories, Pharmaceuticals - Global Strategic Business Report
M2 - Tue Apr 14, 5:36AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tg6qrs/qpcr_and_dpcr) has announced the addition of the "qPCR and dPCR Instrumentation - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for qPCR and dPCR Instrumentation in US$ Thousands by the following Product Segments: qPCR (quantitative Polymerase Chain Reaction), and dPCR (digital Polymerase Chain Reaction). Also, the report analyzes the following End-Uses: Educational/Research, Testing Laboratories, Pharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a four-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. The report profiles 41 companies including many key and niche players such as: - Agilent Technologies, Inc. (US) - Becton, Dickinson and Company (US) - BioFire Diagnostics, Inc. (US) - Bio-Rad Laboratories, Inc. (US) - Cepheid (US) - Eppendorf AG (Germany) - Exiqon A/S (Denmark) - F. Hoffmann-La Roche Ltd. (Switzerland) - Fluidigm Corporation (US) - Illumina, Inc. (US) - Promega Corporation (US) - RainDance Technologies, Inc. (US) - QIAGEN N.V. (Netherlands) - Takara Bio, Inc. (Japan) - Thermo Fisher Scientific Inc. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. GROWTH DRIVERS, MARKET TRENDS & ISSUES 3. COMPETITION 4. END-USE MARKET ANALYSIS 5. PRODUCT OVERVIEW 6. INSIGHT INTO GLOBAL SPENDING ON LIFE SCIENCES RESEARCH 7. PRODUCT INNOVATIONS/INTRODUCTIONS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT GLOBAL PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 41 (including Divisions/Subsidiaries (44) - The United States (26) - Canada (1) - Japan (1) - Europe (15) - Germany (5) - The United Kingdom (2) - Spain (1) - Rest of Europe (7) - Asia-Pacific (Excluding Japan) (1) For more information visit http://www.researchandmarkets.com/research/tg...r_and_dpcr
FLDM: 43.04 (-1.36), A: 42.71 (-0.18), CPHD: 53.14 (-0.78), ILMN: 190.04 (-9.27), QGEN: 24.93 (-0.15)

DexCom Launches CGM App on Apple Watch; Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 13, 12:00PM CDT
DexCom Inc (DXCM) recently announced that its G4 PLATINUM Continuous Glucose Monitoring (CGM) System with Share app will be available on Apple Watch.
ABMD: 69.31 (-0.40), DXCM: 69.28 (-1.05), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04)

AngioDynamics Lags Earnings on Lower Sales, View Tepid - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 10, 9:50AM CDT
AngioDynamics Inc. (ANGO) reported unimpressive third-quarter fiscal 2015 results.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), ANGO: 16.75 (-0.04)

Luminex (LMNX) Launches NxTAG RPP for Respiratory Testing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 07, 10:40AM CDT
Luminex Corp. (LMNX) will be introducing the RUO version of the NxTAG RPP in the clinical market.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), LMNX: 16.34 (-0.01)

Inogen Fails 10-K Deadline; Files Form 12b-25 for Extra Time - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 01, 11:40AM CDT
The filing will provide Inogen Inc. (INGN) with an additional 15 calendar days to file its Form 10-K for the year ended Dec 31, 2014.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

Inogen's Texas Facility Ready, Costs Likely to Scale Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 5:47PM CDT
Inogen Inc (INGN) had decided to lease the Texas facility in December last year for a term of approximately 7 years with the intention of expanding production capacity and lowering the company's average per square foot manufacturing cost.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), EW: 140.87 (+0.39), INGN: 36.39 (-0.04)

Abiomed Attains New 52-Week High on Impella 2.5 Approval - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 25, 10:10AM CDT
Shares of Abiomed Inc (ABMD) scaled a new 52-week high of $74.70 in mid-day trading on Mar 24 after the company announced late Monday that the FDA had approved its Impella 2.5 heart pump.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

Abiomed's Impella 2.5 FDA-Approved for PCI Procedures - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 11:50AM CDT
Abiomed Inc. (ABMD) recently announced that its Impella 2.5 heart pump has received FDA Pre-Market Approval (PMA) for use in high risk percutaneous coronary intervention (PCI) procedures.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

The Best Small Cap Stocks To Buy This Week
Todd Campbell - at Seeking Alpha - Sat Mar 21, 11:24PM CDT

DMND: 30.74 (+0.01), PMC: 28.80 (+0.80), MATW: 50.74 (+0.08), ELLI: 57.00 (-0.45), WWE: 14.19 (+0.04), SILC: 41.72 (+0.45), SGMO: 14.37 (-0.03), TRNX: 25.96 (-0.06), OFIX: 36.22 (-0.21), AFFX: 12.57 (-0.13), CHE: 122.49 (+0.25), BABY: 41.64 (+1.71), HBIO: 6.06 (-0.29), IART: 59.75 (-0.26), SONC: 30.75 (+0.14), SNCR: 51.87 (+0.02), CNMD: 49.35 (+0.36), BJRI: 50.54 (-1.00), NLNK: 53.12 (-0.07), ANAC: 66.45 (-0.22), XSD: 89.10 (+0.13), PRSC: 49.43 (+0.42), RRGB: 80.99 (-2.02), IPAR: 32.16 (+0.16), ALOG: 87.92 (+0.38), DIOD: 28.02 (+0.12), NSIT: 29.01 (+0.22), LGND: 87.71 (-0.58), DEPO: 27.14 (+0.65), ASTE: 42.80 (+0.16), DYAX: 28.12 (+0.15), ECOL: 48.69 (+0.16), PFPT: 58.45 (-0.45), MTSI: 34.46 (-0.27), IRWD: 15.07 (-0.19), ABAX: 63.25 (-0.09), FLDM: 43.04 (-1.36), SCSS: 34.12 (+0.30), ANIP: 69.79 (+1.24), FORM: 9.44 (+0.05), BEAT: 8.82 (-0.13), QLGC: 15.08 (+0.44), ADUS: 27.60 (-0.33), PENX: 18.98 (+0.14), EBIX: 29.77 (+0.86), CORT: 6.44 (+0.38), SWHC: 14.68 (-0.12), OCFC: 16.93 (+0.01)

Cantel Medical Beats Q2 Earnings, Provides Positive Outlook - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 9:00AM CDT
Cantel Medical Corp (CMN) reported adjusted EPS of 36 cents in the second quarter of fiscal 2015, which beat the Zacks Consensus Estimate by 9 cents
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), CMN: 48.33 (+0.23)

Inogen (INGN) Postpones Q4 Results; Reiterates 2015 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 12:30PM CDT
Inogen Inc (INGN) has postponed its fourth quarter and fiscal 2014 earnings release and will announce results as soon as feasible following the completion of the Audit Committee's investigation.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), INGN: 36.39 (-0.04), EW: 140.87 (+0.39)

'Mad Money' Lightning Round: Buy, Buy, Buy Spirit Airlines
at The Street - Tue Mar 10, 5:00AM CDT
Cramer is concerned about Chicago Bridge & Iron, thinks Ecolab is a terrific stock and wants no part of Telefonica Brasil.
CBI: 49.62 (-1.62), CY: 13.57 (+0.11), ESPR: 100.53 (-2.60), SAVE: 77.25 (+0.19), RIG: 16.85 (-0.18), TMO: 130.69 (-3.75), FLDM: 43.04 (-1.36), CAMP: 20.87 (+4.19), SRCL: 139.66 (+0.28), GSAT: 3.14 (-0.06), VIV: 16.29 (+0.61), ECL: 116.05 (+0.17)

Stay Away From Brazilian Stocks - Cramer's Lightning Round (3/9/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Tue Mar 10, 4:26AM CDT
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, March 9. Bullish Calls: Spirit Airlines (NASDAQ: SAVE ): "You know I like Spirit Air. I like Ben Baldanza and I think they are going to do fine. I...
CBI: 49.62 (-1.62), CY: 13.57 (+0.11), TMO: 130.69 (-3.75), CAMP: 20.87 (+4.19), GSAT: 3.14 (-0.06), VIV: 16.29 (+0.61), PBR: 8.93 (+0.35), ESPR: 100.53 (-2.60), SAVE: 77.25 (+0.19), RIG: 16.85 (-0.18), FLDM: 43.04 (-1.36), VALE: 6.50 (+0.61), SRCL: 139.66 (+0.28), CODE: 38.59 (+0.47), ECL: 116.05 (+0.17)

Jim Cramer's 'Mad Money' Recap: 6 Years of Market Gains, 10 Years of 'Mad Money'
at The Street - Mon Mar 09, 7:29PM CDT
Cramer celebrates two anniversaries this week: the 'Haines bottom' of six years ago and the debut of his CNBC show.
CBI: 49.62 (-1.62), CY: 13.57 (+0.11), TMO: 130.69 (-3.75), CAMP: 20.87 (+4.19), GSAT: 3.14 (-0.06), VIV: 16.29 (+0.61), PEP: 97.28 (+0.50), SBUX: 48.33 (-0.04), ESPR: 100.53 (-2.60), SAVE: 77.25 (+0.19), RIG: 16.85 (-0.18), FLDM: 43.04 (-1.36), SRCL: 139.66 (+0.28), AAPL: 128.62 (+1.71), REGN: 472.63 (+9.41), ECL: 116.05 (+0.17)

Symmetry Surgical Posts Loss in Q4, Revenues Decline Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Mar 02, 10:50AM CST
Symmetry Surgical Inc. (SSRG) reported loss of $3.08 per share in the fourth quarter of 2014, which compares unfavorably with the year-ago quarter earnings of 4 cents.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), SSRG: 7.56 (+0.03), LMNX: 16.34 (-0.01)

Teleflex Hits 52-Week High on Strong Q4, Strategic Deals - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 24, 7:16AM CST
Shares of Teleflex Inc (TFX) scaled a new 52-week high of $123.09 in mid-day trading on Feb 23.
ABMD: 69.31 (-0.40), FLDM: 43.04 (-1.36), TFX: 123.02 (+0.27), LMNX: 16.34 (-0.01)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Small Business Insurance Is a Costly Blind Spot Today

Updated Category News Views 32

A busted pipe, a fender-bender, or one bad fall can turn a promising little company into a very expensive regret. That is the plain-English value in insurance expert Michael Oehrke's overview for HelloNation: small-business insurance is not glamorous, it is not growth marketing, and it is often ignored until the owner is staring at a bill that can chew through years of...

Continue Reading
LevelTen Takes Its Clean-Power Market Model to India

Updated Category News Views 89

India's power market is not a tidy spreadsheet, thankfully. It is a vast, fast-growing grid where data centres, factories and climate exposure are all colliding with a generation mix still dominated by coal. That is why LevelTen Energy's move into Asia-Pacific deserves more than the usual clean-tech applause line. Beginning with a 500 MW clean-energy request for proposals...

Continue Reading
Vizsla's Panuco Delay Puts Security Ahead of Speed

Updated Category News Views 73

A mine schedule can absorb a calendar slip; the people around a mine cannot be treated like a line item. Vizsla Silver's update on Panuco is therefore not the usual development-company chest thumping. It is a sober admission that security, permitting and site readiness have pushed first silver to the second half of 2028, one year later than the prior H2 2027 target....

Continue Reading
Abbe Lane Estate Puts Jewelry Demand on Full Display

Updated Category News Views 40

Glamour Is Walking Back Into the Auction Room Abbe Lane’s jewelry is not being offered as a vague nostalgia exercise; it is arriving with dates, a setting, and a clear split between two December sales. John Moran Auctioneers will lead with The Estate of Abbe Lane on Wednesday, December 9, 2026, at 10:00 a.m. PST, then follow with its Jewelry & Watches auction on...

Continue Reading
Elijah Craig Uses AI Toasts to Sell a Warmer Pour

Updated Category News Views 129

A Speech Prompt With a Bourbon Label Few things expose holiday nerves faster than a raised glass and a room waiting for somebody to say something memorable. Elijah Craig has decided that awkward little moment is marketing territory, rolling out its Digital Perfect Pour, Perfect Toast Generator for mobile and desktop users ahead of the holiday season. The tool asks for a...

Continue Reading
Stanford Forum Puts Industrial AI in the Real World

Updated Category News Views 18

Factory Data Is Not a Free Lunch A factory dataset is worth precisely nothing if its owner cannot control it. That was the hard-nosed thread running through the ASI City Forum at Stanford on November 17: industrial AI is not just about smarter models or splashy chip announcements. It is about whether manufacturers will trust a system with proprietary operating data,...

Continue Reading
Disney Springs Hotel Rates Test Holiday Demand Depth

Updated Category News Views 192

A $145 room rate is the sort of holiday bait that gets my attention before the fake snow does. Disney Springs Resort Area Hotels are extending a seasonal offer for stays through Dec. 18, 2026, with bookings open only through Nov. 20. That is a very narrow selling window, and it tells you plenty: these seven independent hotels want to fill rooms during a lucrative but...

Continue Reading
LiberNovo's Black Friday Chair Sale Tests Premium Demand

Updated Category News Views 62

Ergonomic chairs are not impulse purchases, and LiberNovo knows it. Its Black Friday push in the United States and Canada runs through November 30, throwing discounts, gifts, prize-wheel entries and loyalty points at buyers considering a fairly expensive piece of office equipment. That is a lot of promotional machinery for a chair sale, but the underlying pitch is...

Continue Reading
Rescue Dog Wines Puts Holiday Bottles to Work for Dogs

Updated Category News Views 74

A Bottle With a Job Beyond the Table Holiday wine promotions usually arrive wrapped in the same tired ribbon: buy more, save a little, pour it at a party, forget it by January. Rescue Dog Wines is taking a more grounded route. The family-owned Lodi-area winery says it gives 50% of profits to animal rescue organizations, and that commitment is not being dressed up as a...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 122

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading

Top 5 Most Recently Viewed Articles

Legit Security Named as a Top Performer in Application Security

Updated Category News Views 210

Legit Security Recognized as a Leader in Application Security Legit Security, a leader in AI-native Application Security Posture Management (ASPM), has recently been acknowledged as a prominent player in the IDC MarketScape for ASPM. This achievement reflects the company's commitment to securing AI-powered application development processes. The IDC MarketScape report...

Continue Reading
Active Dental Transforms Patient Experience with New Website

Updated Category News Views 140

Active Dental Enhances Patient Accessibility with Unified Website Active Dental, a reputable family and general dentistry practice in the Dallas-Fort Worth metroplex, has launched a newly redesigned website that seamlessly integrates all five of its practice locations into a single, user-friendly digital platform. This significant upgrade aims to make appointment...

Continue Reading
Stork Club's Innovative Approach to Postpartum Depression Support

Updated Category News Views 229

Stork Club Innovates Reproductive Health Care Stork Club has recently launched an unprecedented initiative aimed at addressing postpartum depression (PPD) among working mothers. This pioneering program offers a seamless blend of digital diagnostics and therapy, leading to significant improvements in mental health outcomes. With up to 20% immediate relief from PPD symptoms...

Continue Reading
Investors Eye Class Action Against Fortrea Holdings, Inc.

Updated Category News Views 114

Understanding the Fortrea Holdings, Inc. Class Action Fortrea Holdings, Inc. (NASDAQ: FTRE) has gained attention due to rising investor concerns regarding its recent financial disclosures. Investors who have experienced losses over $100,000 are now presented with an opportunity to potentially lead a securities fraud lawsuit against the company. This lawsuit highlights...

Continue Reading
Alpha Tau Medical Plans Engagements at Key Healthcare Events

Updated Category News Views 91

Upcoming Participation in Major Healthcare Conferences Alpha Tau Medical Ltd., a leading developer of innovative cancer therapies, is gearing up for an exciting presence at significant healthcare conferences. The involvement of the Chief Financial Officer, Raphi Levy, at these events marks a pivotal opportunity for the company to showcase its groundbreaking...

Continue Reading